6th Edelris Annual Symposium on Affinity Selection Mass Spectrometry (AS-MS) in Drug Discovery, co-hosted by AstraZeneca!
We’re excited to announce the 6th Edelris Annual Symposium on Affinity Selection Mass Spectrometry (AS-MS) in Drug Discovery! Join us as we bring together leaders from industry and academia to share their research on emerging technologies, case studies, and applications of AS-MS, shaping the future of small molecule discovery.
Whether you’re developing novel screening platforms, driving medicinal chemistry programs, or exploring new modalities at the frontiers of chemical biology, this event will be a unique opportunity to connect with peers, exchange ideas, and explore where the field is headed.
Date: Thursday, 3rd September 2026
Location: The Discovery Centre (DISC), Cambridge, UK
Further details and registration information will be available soon, but for now, please mark your calendars!
Previous events
2025 Edition
As part of Edelris’s 20th-anniversary celebrations, this symposium marked two decades of innovation in small-molecule drug discovery and highlighted recent advances in hit identification using AS-MS. It brought together leading voices from both academia and industry to share cutting-edge developments in tackling challenging drug targets.
Sponsored by
![]()
2024 Edition
The fourth edition of the symposium opened with the presentation of new AS-MS perspectives, introducing CIAS-MS as a new technology offering the possibility to analyze by mass spectrometry, both the protein/ligand complex and its dissociated form. Various technical aspects of screening platforms dedicated to hit identification were discussed. The successes leading to the development of molecular tools to explore new targets were also presented.
2023 Edition
The program focused on the techniques developed by pharma and CRO organizations to implement AS-MS in their drug discovery process. Automated Data Processing was discussed and the synergy with other HTS technologies, particularly DELT, was emphasized.
2022 Edition
The program covered several aspects of AS-MS, featuring recent technological developments and exciting results on hot targets using various chemical matters including ultra-large libraries of peptides.
2021 Edition
The 1st Edelris Symposium highlighted the use of Affinity Selection-Mass Spectrometry (AS-MS) techniques to explore broad chemical spaces – biased collections, natural products, and large libraries.
